BASILEA PHARM.NA SF 1 earnings per share and revenue

PK5 earnings per share for the last semiannual are -1.83 EUR whereas the estimation was -2.16 EUR which accounts for 14.96% surprise. Company revenue for the same period amounts to 78.41 M EUR despite the estimated figure of 77.41 M EUR. Estimated earnings per share for the next semiannual are 1.22 EUR, and revenue is expected to reach 94.55 M EUR. Also watch annual changes over time to get a bigger picture of PK5 earnings per share and revenue dynamics.